|
|
|
Volumn 98, Issue 4, 1996, Pages 800-
|
|
Acellular pertussis trial [5]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PERTUSSIS TOXIN;
PERTUSSIS VACCINE;
ANTIBODY TITER;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG STABILITY;
HUMAN;
IMMUNIZATION;
IMMUNOGENICITY;
LETTER;
PERTUSSIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
VACCINATION;
ANTIGENS, BACTERIAL;
BORDETELLA PERTUSSIS;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC;
HUMANS;
PERTUSSIS VACCINE;
|
|
EID: 0029848091
PISSN: 00314005
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
